Programming Lasting Health

RNA-guided therapies built on causal biology to reverse disease-driving cell states and restore health.

Scroll To Discover

Highlighted news (02)

View all

HAYA Therapeutics Raises $65 Million in Series A Funding

HAYA Therapeutics Announces Collaboration with Lilly

Our Differentiated Approach

01

Programmable Therapeutics for Causal Biology

We reprogram the cell states that drive disease at its roots with RNA-guided precision. Our platform integrates multimodal functional genomics with proprietary computational tools to decode the 98% of the genome that doesn’t code for proteins, also known as “genome dark matter” or regulatory genome.

By identifying, drugging, and tracking the non-coding RNAs that causally drive disease, we advance programmable RNA therapeutics designed to restore cellular health and deliver lasting impact.

Discover Our Approach
Scientist working in a high-end laboratory.

HAYA’s Blueprint

02
Discover Who We Are

Discover

03

Explore HAYA

From Root Cause to Real Impact

Pipeline

Discover our development programs across diverse therapeutics applications.

Our Pipeline

Working Together

Partnership

We collaborate with pioneers to accelerate innovation.

Let’s Collaborate

Life at HAYA

Careers

Be part of a meaningful journey to deliver life-changing medicines.

Join Our Mission

Advancing Medicine, Together

04

Supporters & Awards